Kevin Buehler
Director · PRECISION BIOSCIENCES INC
- 2024
- Jun 5, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kevin Buehler files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael Amoroso - $246K in DTIL purchases and sales in the last 12 months
- John Alexander Kelly - $101K in DTIL purchases and sales in the last 12 months
- J. Jefferson Smith - $60K in DTIL purchases and sales in the last 12 months
- Dario Scimeca - $59K in DTIL purchases and sales in the last 12 months
- Geno J. Germano - $16K in DTIL purchases and sales in the last 12 months
- Melinda Brown - $7K in DTIL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kevin Buehler?
Kevin Buehler is a corporate insider, tracked as Director of PRECISION BIOSCIENCES INC (DTIL). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Kevin Buehler last file a Form 4?
The most recent primary Form 4 on record is dated 5 June 2026, one of 3 filings going back to 2024.
Has Kevin Buehler been buying or selling stock?
Recorded transactions: 1 open-market purchase ($21K) and 0 open-market sales across all tracked filings.
